AMTX Q1 2026: Aemetis leans into RNG growth and tax credits, nudging earnings optics higher

Lede: AMTX’s quarter through the lens of EPS chatter and revenue trajectory

In its first quarter of 2026, Aemetis, Inc. (AMTX) reports a clear tilt toward revenue growth and positive gross profit, even as the company continues to operate with a non-GAAP-friendly operating loss. The press release presents revenues of $54.6 million—up 27% from a year earlier—alongside a gross profit of $2.8 million, a reversal from a $5.1 million gross loss in Q1 2025. The absence of a stated EPS figure leaves EPS and EPS consensus as topics for market interpretation rather than arithmetic. Investors will also be weighing a potential earnings surprise if future quarters deliver margin expansion and a clearer path to positive earnings per share, versus the current narrative that emphasizes revenue growth and regulatory credits. The revenue forecast for the near term remains a moving target, shaped by RNG volumes, LCFS credits, and the timing of major equipment deliveries.

Financial highlights at a glance

Revenue: $54.6 million, up 27% year over year, with growth spread across California Ethanol, Dairy RNG, and India Biodiesel segments.

Gross profit: $2.8 million, reversing a gross loss of $5.1 million in Q1 2025.

Operating loss: About $6.3 million, an improvement of roughly 60% versus $15.6 million in Q1 2025.

These figures frame a picture where core activities are growing and gross margins are returning to positive territory, but the operating line remains in the red. The question for the EPS debate is whether margin momentum can outpace ongoing overhead and project ramp costs in the quarters ahead.

Operational momentum and production metrics

Aemetis’ renewable offerings are delivering tangible volume gains: Aemetis Biogas RNG sales volume rose 55% to 110,000 MMBtu, up from 71,000 MMBtu in Q1 2025.

India Biodiesel rebounded to $10.5 million in revenue with the resumption of OMC tender shipments under new contracts, supporting diversification within the company’s product mix.

The company also notes progress on infrastructure and pre-constructive milestones: four dairy biogas pretreatment skids began deliveries in April under a $27 million fabrication contract; major equipment deliveries include a $40 million Mechanical Vapor Recompression system for the Keyes ethanol plant and an on-site RNG station intended to directly fuel trucks and gas trailers.

Credits, pathways, and regulatory tailwinds

Aemetis recognized $4.0 million of Section 45Z Production Tax Credits in Q1 2026—the first quarter of ongoing credits generation since 45Z eligibility was established in Q4 2025.

Revenues include LCFS credits earned from seven Dairy RNG pathways with an average CI score of negative 380, versus the negative 150 default pathway that applied for Q1 2025 revenues. Six additional biogas pathways are nearing approval, a potential source of incremental credit value if timing aligns with production ramps.

Strategic context: what this means for AMTX and its peers

The quarter underscores a strategy that blends top-line growth with regulatory credits to cushion margins. The RNG and dairy biogas push reflects a broader shift toward low-emission fuels and waste-to-energy platforms, a theme that could define the competitive landscape for renewable fuels and biogas players in the near term.

From an investor perspective, the absence of a disclosed EPS figure means the traditional EPS consensus and the market’s immediate reaction hinge on margin trajectory and the cadence of tax-credit receipts. If the company can sustain revenue growth while reducing the operating loss and accelerating credit realization, the likelihood of an earnings surprise in future quarters increases—assuming cost discipline keeps pace with growth.

For sector peers, several takeaways emerge: scale the execution risk of large equipment deliveries, monitor regulatory credit regimes (45Z, LCFS), and track the regulatory pathway approvals for additional RNG and biogas projects. The path to profitability in this space remains tied to policy timing as much as plant throughput.

Outlook: risks, opportunities, and the policy backdrop

The quarter’s strengths—revenue growth, moving gross profit into positive territory, and ramping RNG assets—are tempered by the ongoing need to monetize credits and achieve sustained operating leverage. The company’s near-term earnings narrative will depend on (1) the cadence of DAC and RNG production growth, (2) continuation and expansion of LCFS and 45Z credits, and (3) the ability to complete major equipment milestones on budget and on schedule.

In a sector where policy certainty can swing cash flow calculations, AMTX’s progress suggests that investors should watch not just the revenue line but the credit line—the leaner the working capital dynamics around credits, the more likely the company can convert top-line momentum into a clearer earnings path.

Bottom line

AMTX’s Q1 2026 narrative is one of disciplined execution against a backdrop of favorable regulatory credits and strategic project deliveries. Revenue is growing, gross margin is returning to positive, and the ramp of RNG and dairy biogas assets could unlock additional upside as credits timing aligns with production. For readers tracking EPS and EPS consensus, the key near-term question is whether margin expansion can outpace any fixed costs in a capital-heavy growth plan, and whether the tick-tock of 45Z and LCFS credits translates into stronger quarterly earnings as the year unfolds.